Abdel-Fatah, T., Rees, R., Pockley, A., Moseley, P., Ball, G., Chan, S., … Miles, A. (2017). The localization of pre mRNA splicing factor PRPF38B is a novel prognostic biomarker that may predict survival benefit of trastuzumab in patients with breast cancer overexpressing HER2. Oncotarget, 8(68), 112245-112257. https://doi.org/10.18632/oncotarget.22496 (Original work published 2017)